Niagen Bioscience Reports Director/Officer Changes & Shareholder Votes
Ticker: NAGE · Form: 8-K · Filed: Jun 27, 2025 · CIK: 1386570
| Field | Detail |
|---|---|
| Company | Niagen Bioscience, Inc. (NAGE) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, officer-changes, director-changes, shareholder-vote
Related Tickers: CDXC
TL;DR
Niagen Bioscience (CDXC) filed an 8-K detailing exec changes, director elections, and shareholder votes as of 6/24.
AI Summary
Niagen Bioscience, Inc. filed an 8-K on June 27, 2025, reporting on events as of June 24, 2025. The filing covers the departure of directors or officers, election of directors, appointment of officers, and compensatory arrangements. It also includes the submission of matters to a vote of security holders and financial statements/exhibits. The company was formerly known as ChromaDex Corp.
Why It Matters
This 8-K filing indicates significant corporate governance and potential strategic shifts within Niagen Bioscience, Inc., which could impact its future direction and shareholder value.
Risk Assessment
Risk Level: medium — Changes in directors and officers, along with shareholder votes, can signal shifts in strategy or internal dynamics that may carry inherent risks.
Key Players & Entities
- Niagen Bioscience, Inc. (company) — Registrant
- ChromaDex Corp. (company) — Former company name
- June 24, 2025 (date) — Earliest event reported date
- June 27, 2025 (date) — Filing date
FAQ
What specific directors or officers have departed from Niagen Bioscience, Inc. as of June 24, 2025?
The filing indicates the departure of directors or certain officers, but does not name specific individuals in the provided text.
Were any new directors or officers appointed by Niagen Bioscience, Inc. on or before June 24, 2025?
Yes, the filing explicitly mentions the election of directors and the appointment of certain officers as events reported.
What compensatory arrangements for certain officers are detailed in this 8-K filing?
The filing lists 'Compensatory Arrangements of Certain Officers' as an item of information, but the specific details of these arrangements are not provided in the excerpt.
What matters were submitted to a vote of security holders by Niagen Bioscience, Inc. as of June 24, 2025?
The filing states that 'Submission of Matters to a Vote of Security Holders' is an item covered, but the specific matters are not detailed in the provided text.
Does this 8-K filing include financial statements or exhibits for Niagen Bioscience, Inc.?
Yes, the filing explicitly states 'Financial Statements and Exhibits' as an item of information included.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 27, 2025 regarding Niagen Bioscience, Inc. (NAGE).